Crinetics Pharmaceuticals, Inc.

Nasdaq:CRNX

Pharmaceutical Preparations·SAN DIEGO, CA

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F.

CEO

Struthers Richard Scott

CFO

Schilke Tobin

All Filings(646 total)

TypeDateAccessionPeriodSize

Mar 13, 2026

0001628280-26-017797FORM 4

Mar 12, 2026

6.7 KB

144

Mar 12, 2026

0001950047-26-002543

—

4.6 KB

Mar 4, 2026

0001628280-26-014775FORM 4

Mar 3, 2026

4.8 KB

Mar 4, 2026

0001628280-26-014772FORM 4

Mar 3, 2026

5.2 KB

144

Mar 3, 2026

0001950047-26-002102

—

4.6 KB

8-K

Mar 3, 2026

0001658247-26-0000178-K

Feb 27, 2026

143.7 KB

144

Mar 2, 2026

0001628280-26-013047

—

4.4 KB

S-8

Feb 26, 2026

0001658247-26-000014S-8

—

252.8 KB

10-K

Feb 26, 2026

0001658247-26-00001210-K

Dec 31, 2025

9.8 MB

8-K

Feb 26, 2026

0001658247-26-0000118-K

Feb 26, 2026

288.2 KB

Feb 25, 2026

0001628280-26-011730FORM 4

Feb 23, 2026

10.3 KB

Feb 25, 2026

0001628280-26-011728FORM 4

Feb 23, 2026

7.0 KB

Feb 25, 2026

0001628280-26-011723FORM 4

Feb 23, 2026

7.0 KB

Feb 25, 2026

0001628280-26-011718FORM 4

Feb 23, 2026

6.9 KB

Feb 25, 2026

0001628280-26-011715FORM 4

Feb 23, 2026

6.9 KB

SCHEDULE 13G/A

Feb 5, 2026

0000908834-26-000040

—

61.0 KB

144

Feb 2, 2026

0001950047-26-000824

—

6.9 KB

8-K

Jan 26, 2026

0001658247-26-0000038-K

Jan 20, 2026

136.1 KB

8-K

Jan 13, 2026

0001193125-26-0118728-K

Jan 13, 2026

6.4 MB

Jan 7, 2026

0001628280-26-001230FORM 4

Jan 5, 2026

8.7 KB

8-K

Jan 7, 2026

0001193125-26-0064218-K

Jan 5, 2026

466.2 KB

424B5

Jan 7, 2026

0001193125-26-006276424B5

—

656.0 KB

144

Jan 5, 2026

0001950047-26-000146

—

4.6 KB

424B5

Jan 5, 2026

0001193125-26-002458424B5

—

514.6 KB

8-K

Jan 5, 2026

0001193125-26-0023688-K

Jan 5, 2026

11.8 MB

25 filings shown